HUBOT, INC. — SEC Form D Filing

HUBOT, INC. filed an SEC Form D on April 7, 2026, reporting $5.50M raised in Pharmaceuticals.

Form D filing details

Filing
SEC Form D
Filing date
April 7, 2026
Amount reported
$5.50M
Round stage
Seed
Industry
Pharmaceuticals
Website
https://hubot.github.com/

What the company does

Securities: Equity. Revenue: $25,000,001 - $100,000,000. Exemption: Rule 506(b). Incorporated: INDIANA

Problem

Pharmaceutical companies often struggle with drug discovery and development processes.

Solution

HUBOT provides technology solutions that streamline drug discovery and enhance collaboration in the pharmaceutical industry.

Verdict

Investors said yes at this moment because they perceived HUBOT's technology as a potential game changer in the challenging drug discovery landscape, not because the narrative provided a clear picture of who specifically would pay for it. They were implicitly betting on a broader need for innovation in pharmaceuticals amid increasing competition, but the lack of specification regarding buyers and budget owners limited the narrative's upside and durability.

Source: SEC EDGAR Form D filing